Search research articles
Contact Us
Filters
Showing results (691-700 of 756) with videos related to
Page
of 76
Sort By:
Leukemia Research
|
November 13, 2021
Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial
Selina M Luger, Victoria X Wang, Jacob M Rowe, et al.
Bone Marrow Transplantation
|
October 18, 2011
Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies
T L Kindwall-Keller, Y Hegerfeldt, H J Meyerson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells
J N Winter, H M Lazarus, A Rademaker, et al.
Cancer Chemotherapy and Pharmacology
|
February 22, 2012
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies
Prithviraj Bose, Edward B Perkins, Connie Honeycut, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 20, 2022
Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer
D Gale, K Heider, A Ruiz-Valdepenas, et al.
Blood Advances
|
January 3, 2024
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia
Leland L Metheny, Ronald Sobecks, Christina Cho, et al.
Genome Research
|
November 12, 2021
Long-read assembly and comparative evidence-based reanalysis of <i>Cryptosporidium</i> genome sequences reveal expanded transporter repertoire and duplication of entire chromosome ends including subtelomeric regions
Rodrigo P Baptista, Yiran Li, Adam Sateriale, et al.
The Review of Scientific Instruments
|
November 7, 2012
Copper activation deuterium-tritium neutron yield measurements at the National Ignition Facility
G W Cooper, C L Ruiz, R J Leeper, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 19, 2002
Breast cancer cell contamination of blood stem cell products in patients with metastatic breast cancer: predictors and clinical relevance
Andrew L Pecora, Hillard M Lazarus, Andrew A Jennis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 28, 2023
Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML
Keith W Pratz, Mohamad Cherry, Jessica K Altman, et al.
Page
of 76
Search research articles
Search
Showing results (691-700 of 756) with videos related to
Sort By:
Page
of 76
Leukemia Research
|
November 13, 2021
Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial
Selina M Luger, Victoria X Wang, Jacob M Rowe, et al.
Bone Marrow Transplantation
|
October 18, 2011
Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies
T L Kindwall-Keller, Y Hegerfeldt, H J Meyerson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells
J N Winter, H M Lazarus, A Rademaker, et al.
Cancer Chemotherapy and Pharmacology
|
February 22, 2012
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies
Prithviraj Bose, Edward B Perkins, Connie Honeycut, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 20, 2022
Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer
D Gale, K Heider, A Ruiz-Valdepenas, et al.
Blood Advances
|
January 3, 2024
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia
Leland L Metheny, Ronald Sobecks, Christina Cho, et al.
Genome Research
|
November 12, 2021
Long-read assembly and comparative evidence-based reanalysis of <i>Cryptosporidium</i> genome sequences reveal expanded transporter repertoire and duplication of entire chromosome ends including subtelomeric regions
Rodrigo P Baptista, Yiran Li, Adam Sateriale, et al.
The Review of Scientific Instruments
|
November 7, 2012
Copper activation deuterium-tritium neutron yield measurements at the National Ignition Facility
G W Cooper, C L Ruiz, R J Leeper, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 19, 2002
Breast cancer cell contamination of blood stem cell products in patients with metastatic breast cancer: predictors and clinical relevance
Andrew L Pecora, Hillard M Lazarus, Andrew A Jennis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 28, 2023
Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML
Keith W Pratz, Mohamad Cherry, Jessica K Altman, et al.
Page
of 76